P/E ratio for Inogen (INGN)
P/E ratio as of April 2024 (TTM): -1.62
According to Inogen's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.61575. At the end of 2022 the company had a P/E ratio of -5.39.
P/E ratio history for Inogen from 2014 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -5.39 | -95.72% |
| 2021 | -126 | -26.72% |
| 2020 | -172 | -341.43% |
| 2019 | 71.2 | 39.87% |
| 2018 | 50.9 | -56.84% |
| 2017 | 118 | 80.79% |
| 2016 | 65.2 | -2.4% |
| 2015 | 66.8 | -31.84% |
| 2014 | 98.0 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 ResMed RMD | 35.4 | -2,289.69% | 🇺🇸 USA |
 Masimo MASI | 61.8 | -3,927.67% | 🇺🇸 USA |
 Chart Industries GTLS | -90.1 | 5,473.69% | 🇺🇸 USA |
 Allied Healthcare Products AHPI | -0.0042 | -99.74% | 🇺🇸 USA |
 Philips PHG | -29.6 | 1,729.45% | 🇳🇱 Netherlands |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.